Brief: Lavipharm FY 2023 Net Profit Up At EUR 1.9 Million
28/02/2024 15:28
Feb 28 (Reuters) - Lavipharm SA LPHr.AT :
* FY 2023 NET PROFIT EUR 1.87 MILLION VERSUS EUR 0.8 MILLION
YEAR
AGO
* FY 2023 EBITDA FROM ONGOING OPERATIONS EUR 9.6 MILLION
VERSUS
EUR 5.6 MILLION YEAR AGO
* FY 2023 TOTAL SALES BEFORE CLAWBACK-REBATES FROM
CONTINUING
OPERATIONS EUR 57.4 MILLION VERSUS EUR 45.1 MILLION YEAR AGO
Further company coverage: LPHr.AT
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Lavipharm SA
See all newsBrief: Lavipharm Q1 Earnings Before Tax From Continuing Operations €1.41 Million, Up 28.6% YoY
Brief: Lavipharm To Acquire Durogesic Pain Patch Rights From Janssen For $12.0 Million
Brief: Lavipharm SA FY 2025 Earnings After Tax EUR 6.0 Million Versus EUR 9.0 Million Year Ago
Brief: Lavipharm 9-Month Net Profit Down To EUR 3.5 Million
Brief: Lavipharm H1 Adjusted EBITDA At EUR 7.7 Million, Up 29.4% YoY